Gene · 93
Papers1,693
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
61 to 80 of 1,693
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The Clinical Development of Taldefgrobep Alfa: An Anti-Myostatin Adnectin for the Treatment of Duchenne Muscular Dystrophy. | Neurol Ther | 2024 | 38190001 | PubTator, text mining | PubMed |
| A novel disulfidptosis-related lncRNAs signature for predicting survival and immune response in hepatocellular carcinoma. | Aging (Albany NY) | 2024 | 38180745 | PubTator, text mining | PubMed |
| Cholesterol modulates type I/II TGF-β receptor complexes and alters the balance between Smad and Akt signaling in hepatocytes. | Commun Biol | 2024 | 38168942 | PubTator, text mining | PubMed |
| Activin A induces apoptosis of human lung adenocarcinoma A549 cells through endoplasmic reticulum stress pathway. | Oncol Rep | 2024 | 38131250 | PubTator, text mining | PubMed |
| Cancer cachexia: Focus on cachexia factors and inter-organ communication. | Chin Med J (Engl) | 2024 | 37968131 | PubTator, text mining | PubMed |
| Bone morphogenetic protein 6 induces downregulation of pentraxin 3 expression in human granulosa lutein cells in women with polycystic ovary syndrome. | J Assist Reprod Genet | 2024 | 37930517 | PubTator, text mining | PubMed |
| Skeletal muscle myostatin mRNA expression is upregulated in aged human adults with excess adiposity but is not associated with insulin resistance and ageing. | Geroscience | 2024 | 37801203 | PubTator, text mining | PubMed |
| Bioinformatics Analysis of the Genetic and Epigenetic Alterations of Bone Morphogenetic Protein Receptors in Metastatic Breast Cancer. | Biochem Genet | 2024 | 37486509 | PubTator, text mining | PubMed |
| Inhibition of anti-tumor immunity by melanoma cell-derived Activin-A depends on STING. | Front Immunol | 2023 | 38304252 | PubTator, text mining | PubMed |
| Circular RNAs: Promising Treatment Targets and Biomarkers of Ischemic Stroke. | Int J Mol Sci | 2023 | 38203348 | PubTator, text mining | PubMed |
| ACVR1: A Novel Therapeutic Target to Treat Anemia in Myelofibrosis. | Cancers (Basel) | 2023 | 38201581 | PubTator, text mining | PubMed |
| Navigating the Complex Landscape of Fibrodysplasia Ossificans Progressiva: From Current Paradigms to Therapeutic Frontiers. | Genes (Basel) | 2023 | 38136984 | PubTator, text mining | PubMed |
| Myostatin and the Heart. | Biomolecules | 2023 | 38136649 | PubTator, text mining | PubMed |
| The Role of Exercise in Cancer-Related Sarcopenia and Sarcopenic Obesity. | Cancers (Basel) | 2023 | 38136400 | PubTator, text mining | PubMed |
| Molecular Mechanisms and the Interplay of Important Chronic Obstructive Pulmonary Disease Biomarkers Reveals Novel Therapeutic Targets. | ACS Omega | 2023 | 38107961 | PubTator, text mining | PubMed |
| Discovery of ginisortamab, a potent and novel anti-gremlin-1 antibody in clinical development for the treatment of cancer. | MAbs | 2023 | 38084840 | PubTator, text mining | PubMed |
| Genetic variants in myostatin and its receptors promote elite athlete status. | BMC Genomics | 2023 | 38082252 | PubTator, text mining | PubMed |
| Crosstalk of cuproptosis-related prognostic signature and competing endogenous RNAs regulation in hepatocellular carcinoma. | Aging (Albany NY) | 2023 | 38078880 | PubTator, text mining | PubMed |
| BMP signaling in cancer stemness and differentiation. | Cell Regen | 2023 | 38049682 | PubTator, text mining | PubMed |
| Use of AgomiR and AntagomiR technologies to alter satellite cell proliferation in vitro, miRNA expression, and muscle fiber hypertrophy in intrauterine growth-restricted lambs. | Front Mol Biosci | 2023 | 38028550 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/93/papers?page=4